Barclays Downgrades Vitamin Shoppe To Equal-weight

Analysts at Barclays downgraded

from Overweight to Equal-weight. The price target for Vitamin Shoppe has been lowered from $51.00 to $45.00. Vitamin Shoppe shares have dropped 8.98% over the past 52 weeks, while the S&P 500 index has surged 14.65% in the same period. Vitamin Shoppe's shares rose 1.97% to $43.00 in pre-market trading.